Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant

BACKGROUND: Ventricular assist devices(VAD) implantation/removal is a complex surgical procedure with perioperative bleeding complications occurring in nearly half of the cases. Recombinant activated factor VII (rFVIIa) has been used off-label to control severe hemorrhage in surgery and trauma. We r...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gandhi, Manish J, Pierce, Richard A, Zhang, Lini, Moon, Marc R, Despotis, George J, Moazami, Nader
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2007
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1939840/
https://ncbi.nlm.nih.gov/pubmed/17617902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1749-8090-2-32
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg